S2CID 35102048
TRIUMPH-3 (NCT05882045) is a Phase 3, 80-week, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of retatrutide once weekly compared with placebo in participants with severe obesity (Class 2 or Class 3), defined as BMI 35 kg/m 2 , and established cardiovascular disease
Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS)
Neither the information nor the products offered are meant to diagnose, treat, cure, or prevent any medical condition
Focus on nutrition: the role of iodine in nutrition and metabolism
Management includes eating smaller meals, avoiding high-fat foods, staying hydrated, and gradual dose titration as recommended in UK prescribing guidance